Oklahoma Blood Institute provides COVID-19 convalescent plasma for patient care
[ad_1] OKLAHOMA CITY (KFOR) – As COVID-19 continues to change, so must the way doctors fight the virus. This week, the FDA pulled authorization on some monoclonal antibody treatments since they are not working against Omicron. But Oklahoma doctors hope the state’s new and improved COVID-19 convalescent plasma could keep Oklahomans battling the virus out […]
Continue Reading